Work

Supplemental Figure 1 from A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Individual and mean plasma exposures (AUCtau or Cmin) to endocrine therapies alone or in combination with enzalutamide. Note: Box plots provide the mean (red line), median (black line), and 25%/75% quartiles with whiskers to the last point within 1.5-times interquartile range. Sample sizes are reported in Table 2 in the article.

DOI: 10.1158/1078-0432.22469247

Authors: Lee S. Schwartzberg, Denise A. Yardley, Anthony D. Elias, Manish Patel, Patricia LoRusso, Howard A. Burris, Ayca Gucalp, Amy C. Peterson, Martha E. Blaney, Joyce L. Steinberg, Jacqueline A. Gibbons, Tiffany A. Traina

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361887121

Cites:

Cited by:

Related to: 10